vs
Side-by-side financial comparison of Getty Images Holdings, Inc. (GETY) and Protagonist Therapeutics, Inc (PTGX). Click either name above to swap in a different company.
Getty Images Holdings, Inc. is the larger business by last-quarter revenue ($282.3M vs $170.6M, roughly 1.7× Protagonist Therapeutics, Inc). Protagonist Therapeutics, Inc runs the higher net margin — 77.2% vs -32.2%, a 109.4% gap on every dollar of revenue. On growth, Protagonist Therapeutics, Inc posted the faster year-over-year revenue change (184.4% vs 14.1%). Protagonist Therapeutics, Inc produced more free cash flow last quarter ($182.8M vs $7.7M).
Getty Images Holdings, Inc. is a visual media company and supplier of stock images, editorial photography, video, and music for businesses and consumers, with a library of over 477 million assets. It targets three markets—creative professionals, the media, and corporate.
Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel peptide-based targeted therapies for unmet medical needs, primarily covering gastrointestinal disorders, inflammatory diseases and rare disease indications. Its lead product candidates target inflammatory bowel disease and other chronic immune-related conditions, with operations spanning global R&D and partnership collaborations.
GETY vs PTGX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2024
| Metric | | |
|---|---|---|
| Revenue | $282.3M | $170.6M |
| Net Profit | $-90.9M | $131.7M |
| Gross Margin | 74.8% | — |
| Operating Margin | -8.5% | 74.3% |
| Net Margin | -32.2% | 77.2% |
| Revenue YoY | 14.1% | 184.4% |
| Net Profit YoY | -467.6% | 381.7% |
| EPS (diluted) | $-0.22 | $2.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $282.3M | — | ||
| Q3 25 | $240.0M | — | ||
| Q2 25 | $234.9M | — | ||
| Q1 25 | $224.1M | — | ||
| Q4 24 | $247.3M | $170.6M | ||
| Q3 24 | $240.5M | — | ||
| Q2 24 | $229.1M | — | ||
| Q1 24 | $222.3M | $255.0M |
| Q4 25 | $-90.9M | — | ||
| Q3 25 | $21.6M | — | ||
| Q2 25 | $-34.4M | — | ||
| Q1 25 | $-102.6M | — | ||
| Q4 24 | $24.7M | $131.7M | ||
| Q3 24 | $-2.5M | — | ||
| Q2 24 | $3.7M | — | ||
| Q1 24 | $13.6M | $207.3M |
| Q4 25 | 74.8% | — | ||
| Q3 25 | 73.2% | — | ||
| Q2 25 | 72.1% | — | ||
| Q1 25 | 73.1% | — | ||
| Q4 24 | 73.5% | — | ||
| Q3 24 | 73.4% | — | ||
| Q2 24 | 72.5% | — | ||
| Q1 24 | 72.9% | — |
| Q4 25 | -8.5% | — | ||
| Q3 25 | 18.8% | — | ||
| Q2 25 | 15.1% | — | ||
| Q1 25 | 12.2% | — | ||
| Q4 24 | 14.5% | 74.3% | ||
| Q3 24 | 23.9% | — | ||
| Q2 24 | 20.3% | — | ||
| Q1 24 | 18.5% | 80.9% |
| Q4 25 | -32.2% | — | ||
| Q3 25 | 9.0% | — | ||
| Q2 25 | -14.6% | — | ||
| Q1 25 | -45.8% | — | ||
| Q4 24 | 10.0% | 77.2% | ||
| Q3 24 | -1.1% | — | ||
| Q2 24 | 1.6% | — | ||
| Q1 24 | 6.1% | 81.3% |
| Q4 25 | $-0.22 | — | ||
| Q3 25 | $0.05 | — | ||
| Q2 25 | $-0.08 | — | ||
| Q1 25 | $-0.25 | — | ||
| Q4 24 | $0.07 | $2.01 | ||
| Q3 24 | $-0.01 | — | ||
| Q2 24 | $0.01 | — | ||
| Q1 24 | $0.03 | $3.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.2M | $418.9M |
| Total DebtLower is stronger | $1.3B | — |
| Stockholders' EquityBook value | $552.5M | $675.3M |
| Total Assets | $3.2B | $744.7M |
| Debt / EquityLower = less leverage | 2.30× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.2M | — | ||
| Q3 25 | $109.5M | — | ||
| Q2 25 | $110.3M | — | ||
| Q1 25 | $114.6M | — | ||
| Q4 24 | $121.2M | $418.9M | ||
| Q3 24 | $109.9M | — | ||
| Q2 24 | $121.7M | — | ||
| Q1 24 | $134.2M | $322.6M |
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.3B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.4B | — |
| Q4 25 | $552.5M | — | ||
| Q3 25 | $634.6M | — | ||
| Q2 25 | $611.2M | — | ||
| Q1 25 | $593.0M | — | ||
| Q4 24 | $670.2M | $675.3M | ||
| Q3 24 | $683.4M | — | ||
| Q2 24 | $654.0M | — | ||
| Q1 24 | $640.8M | $560.4M |
| Q4 25 | $3.2B | — | ||
| Q3 25 | $2.6B | — | ||
| Q2 25 | $2.6B | — | ||
| Q1 25 | $2.6B | — | ||
| Q4 24 | $2.6B | $744.7M | ||
| Q3 24 | $2.6B | — | ||
| Q2 24 | $2.6B | — | ||
| Q1 24 | $2.6B | $629.3M |
| Q4 25 | 2.30× | — | ||
| Q3 25 | 2.11× | — | ||
| Q2 25 | 2.19× | — | ||
| Q1 25 | 2.21× | — | ||
| Q4 24 | 1.96× | — | ||
| Q3 24 | 1.97× | — | ||
| Q2 24 | 2.06× | — | ||
| Q1 24 | 2.16× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $20.6M | $184.2M |
| Free Cash FlowOCF − Capex | $7.7M | $182.8M |
| FCF MarginFCF / Revenue | 2.7% | 107.1% |
| Capex IntensityCapex / Revenue | 4.6% | 0.8% |
| Cash ConversionOCF / Net Profit | — | 1.40× |
| TTM Free Cash FlowTrailing 4 quarters | $5.7M | $101.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $20.6M | — | ||
| Q3 25 | $22.6M | — | ||
| Q2 25 | $6.5M | — | ||
| Q1 25 | $15.4M | — | ||
| Q4 24 | $39.7M | $184.2M | ||
| Q3 24 | $10.7M | — | ||
| Q2 24 | $46.4M | — | ||
| Q1 24 | $21.5M | $-27.4M |
| Q4 25 | $7.7M | — | ||
| Q3 25 | $7.9M | — | ||
| Q2 25 | $-9.6M | — | ||
| Q1 25 | $-322.0K | — | ||
| Q4 24 | $24.6M | $182.8M | ||
| Q3 24 | $-1.8M | — | ||
| Q2 24 | $31.1M | — | ||
| Q1 24 | $7.1M | $-27.7M |
| Q4 25 | 2.7% | — | ||
| Q3 25 | 3.3% | — | ||
| Q2 25 | -4.1% | — | ||
| Q1 25 | -0.1% | — | ||
| Q4 24 | 9.9% | 107.1% | ||
| Q3 24 | -0.8% | — | ||
| Q2 24 | 13.6% | — | ||
| Q1 24 | 3.2% | -10.9% |
| Q4 25 | 4.6% | — | ||
| Q3 25 | 6.1% | — | ||
| Q2 25 | 6.9% | — | ||
| Q1 25 | 7.0% | — | ||
| Q4 24 | 6.1% | 0.8% | ||
| Q3 24 | 5.2% | — | ||
| Q2 24 | 6.7% | — | ||
| Q1 24 | 6.5% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | 1.05× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.61× | 1.40× | ||
| Q3 24 | — | — | ||
| Q2 24 | 12.59× | — | ||
| Q1 24 | 1.58× | -0.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GETY
| Creative | $149.0M | 53% |
| Editorial | $109.4M | 39% |
| Other | $23.9M | 8% |
PTGX
Segment breakdown not available.
